PDF(Pubmed)
Abstract：
UNASSIGNED: There is limited literature evaluating patient-reported outcomes (PROs) in cigarette smokers undergoing hip arthroscopy for femoroacetabular impingement syndrome (FAIS) at midterm follow-up.
UNASSIGNED: (1) To report minimum 5-year PROs for cigarette-smoking patients who underwent primary hip arthroscopy for FAIS and (2) to compare these results with a propensity-matched control group of never-smoking patients.
UNASSIGNED: Cohort study; Level of evidence, 3.
UNASSIGNED: Data were collected for all patients who underwent primary hip arthroscopy for FAIS between June 2009 and March 2016. Patients were eligible if they indicated that they smoked cigarettes within 1 month of surgery and had minimum 5-year postoperative outcomes for the modified Harris Hip Score, Nonarthritic Hip Score, Hip Outcome Score-Sport Specific Subscale (HOS-SSS), and International Hip Outcome Tool-12 (iHOT-12). The percentages of patients achieving the Patient Acceptable Symptom State (PASS) and maximum outcome improvement satisfaction threshold were recorded. The study group was then propensity matched in a 1:2 ratio to patients who had never smoked for comparison.
UNASSIGNED: Included were 35 patients (35 hips) with a mean age of 39.4 ± 13.0 years and mean follow-up of 64.6 ± 4.1 months. These patients demonstrated significant improvement from preoperatively to a minimum 5-year follow-up for all recorded PROs (P < .05). When compared with 70 control patients (70 hips), smoking patients demonstrated significantly worse preoperative scores for all PROs (P < .05). Study patients also demonstrated worse minimum 5-year scores for all recorded PROs compared with control patients, which did not reach statistical significance but trended toward significance for HOS-SSS (70.4 vs 81.9; P = .076) and iHOT-12 (74.7 vs 82.2; P = .122). Smoking patients also trended toward lower rates of achieving PASS for the iHOT-12 compared with never-smoking patients (50.0% vs 68.2%; P = .120).
UNASSIGNED: Patients who smoked cigarettes and underwent primary hip arthroscopy for FAIS demonstrated significant improvement in PROs at a minimum 5-year follow-up. When compared with a propensity-matched control group of never-smokers, they trended toward lower postoperative HOS-SSS and iHOT-12 scores and lower rates of achieving PASS on the iHOT-12.
UNASSIGNED: (1) To report minimum 5-year PROs for cigarette-smoking patients who underwent primary hip arthroscopy for FAIS and (2) to compare these results with a propensity-matched control group of never-smoking patients.
UNASSIGNED: Cohort study; Level of evidence, 3.
UNASSIGNED: Data were collected for all patients who underwent primary hip arthroscopy for FAIS between June 2009 and March 2016. Patients were eligible if they indicated that they smoked cigarettes within 1 month of surgery and had minimum 5-year postoperative outcomes for the modified Harris Hip Score, Nonarthritic Hip Score, Hip Outcome Score-Sport Specific Subscale (HOS-SSS), and International Hip Outcome Tool-12 (iHOT-12). The percentages of patients achieving the Patient Acceptable Symptom State (PASS) and maximum outcome improvement satisfaction threshold were recorded. The study group was then propensity matched in a 1:2 ratio to patients who had never smoked for comparison.
UNASSIGNED: Included were 35 patients (35 hips) with a mean age of 39.4 ± 13.0 years and mean follow-up of 64.6 ± 4.1 months. These patients demonstrated significant improvement from preoperatively to a minimum 5-year follow-up for all recorded PROs (P < .05). When compared with 70 control patients (70 hips), smoking patients demonstrated significantly worse preoperative scores for all PROs (P < .05). Study patients also demonstrated worse minimum 5-year scores for all recorded PROs compared with control patients, which did not reach statistical significance but trended toward significance for HOS-SSS (70.4 vs 81.9; P = .076) and iHOT-12 (74.7 vs 82.2; P = .122). Smoking patients also trended toward lower rates of achieving PASS for the iHOT-12 compared with never-smoking patients (50.0% vs 68.2%; P = .120).
UNASSIGNED: Patients who smoked cigarettes and underwent primary hip arthroscopy for FAIS demonstrated significant improvement in PROs at a minimum 5-year follow-up. When compared with a propensity-matched control group of never-smokers, they trended toward lower postoperative HOS-SSS and iHOT-12 scores and lower rates of achieving PASS on the iHOT-12.
摘要：
UNASSIGNED：在中期随访中，有限的文献评估了吸烟者接受髋关节镜检查治疗股骨髋臼撞击综合征（FAIS）的患者报告结果（PRO）。
UNASSIGNED：（1）报告吸烟患者接受FAIS初次髋关节镜检查的至少5年PROs，（2）将这些结果与倾向匹配的对照组进行比较从不吸烟患者。
未经批准：队列研究；证据水平，3.
UNASSIGNED：收集了2009年6月至2016年3月期间接受FAIS初次髋关节镜检查的所有患者的数据。如果患者表明他们在手术后1个月内吸烟，并且改良的Harris髋关节评分术后至少5年结果，则患者符合条件。非关节炎髋关节评分,髋关节结果评分-运动特定分量表(HOS-SSS)，和国际髋关节结果工具-12（iHOT-12）。记录达到患者可接受症状状态(PASS)和最大结果改善满意度阈值的患者百分比。然后，研究组与从未吸烟的患者以1：2的比例进行倾向匹配，以进行比较。
UNASSIGNED：包括35例患者（35髋），平均年龄为39.4±13.0岁，平均随访时间为64.6±4.1个月。这些患者在术前到至少5年随访的所有记录的PROs均表现出显着改善（P<0.05）。与70名对照组患者（70髋）相比，吸烟患者的术前评分均显著较差(P<.05).与对照组患者相比，研究患者的所有记录PRO的最低5年得分也较差。HOS-SSS（70.4vs81.9；P=.076）和iHOT-12（74.7vs82.2；P=.122）没有达到统计学意义，但趋势明显。与从不吸烟的患者相比，吸烟的患者iHOT-12达到PASS的比率也趋于较低（50.0％vs68.2％；P=.120）。
UNASSIGNED：吸烟并接受FAIS初次髋关节镜检查的患者在至少5年的随访中显示出PRO的显着改善。与倾向匹配的从不吸烟者对照组相比，他们倾向于术后HOS-SSS和iHOT-12评分较低，而iHOT-12的通过率较低。
UNASSIGNED：（1）报告吸烟患者接受FAIS初次髋关节镜检查的至少5年PROs，（2）将这些结果与倾向匹配的对照组进行比较从不吸烟患者。
未经批准：队列研究；证据水平，3.
UNASSIGNED：收集了2009年6月至2016年3月期间接受FAIS初次髋关节镜检查的所有患者的数据。如果患者表明他们在手术后1个月内吸烟，并且改良的Harris髋关节评分术后至少5年结果，则患者符合条件。非关节炎髋关节评分,髋关节结果评分-运动特定分量表(HOS-SSS)，和国际髋关节结果工具-12（iHOT-12）。记录达到患者可接受症状状态(PASS)和最大结果改善满意度阈值的患者百分比。然后，研究组与从未吸烟的患者以1：2的比例进行倾向匹配，以进行比较。
UNASSIGNED：包括35例患者（35髋），平均年龄为39.4±13.0岁，平均随访时间为64.6±4.1个月。这些患者在术前到至少5年随访的所有记录的PROs均表现出显着改善（P<0.05）。与70名对照组患者（70髋）相比，吸烟患者的术前评分均显著较差(P<.05).与对照组患者相比，研究患者的所有记录PRO的最低5年得分也较差。HOS-SSS（70.4vs81.9；P=.076）和iHOT-12（74.7vs82.2；P=.122）没有达到统计学意义，但趋势明显。与从不吸烟的患者相比，吸烟的患者iHOT-12达到PASS的比率也趋于较低（50.0％vs68.2％；P=.120）。
UNASSIGNED：吸烟并接受FAIS初次髋关节镜检查的患者在至少5年的随访中显示出PRO的显着改善。与倾向匹配的从不吸烟者对照组相比，他们倾向于术后HOS-SSS和iHOT-12评分较低，而iHOT-12的通过率较低。
